Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26b9352ab71aeaae0c630b469591ebc3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee1f2823cfb50f8cebb69de7f074d4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17022d32d1736efe932f7927503d7616 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2809 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2020-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de99ca63ee980d03301595b4fac14cb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31f87af4c4172bf43e5d9234e9df3329 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_451c1cd79effbb40abbafd5655907c3e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96b6f685b7115887bc81cebf7eec438e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a27a7f43bab34096e81c4ff6bebb8b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_033e434b850334482f4d4e074a341871 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0454270b6e975a214ac5612ee7f468a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3e5a87f8824e58a79d772c3ec64d818 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b77380b055e182ae7f770b5d181423ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc735c0348a4013b813e1d540a42899c |
publicationDate |
2020-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020399370-A1 |
titleOfInvention |
Agents for Treatment of Claudin Expressing Cancer Diseases |
abstract |
The present invention provides binding agents that contain a binding domain that is specific for CD3 allowing binding to T cells and a binding domain that is specific for a tumor-associated claudin molecule and methods of using these binding agents or nucleic acids encoding therefor for treating cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434291-B2 |
priorityDate |
2012-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |